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Helong Zhao, Tasha Wilkie, Yadwinder Deol, Amita Sneh, Akaansha Ganju, Mustafa Basree, Mohd W. Nasser*
and Ramesh K. Ganju*Erratum
After publication of [1] it came to the authors’ attention
that in the abstract. The sentence “In the present study,
we show that S100A7 significantly downregulates the
expression of miR-29b in Estrogen Receptor (ER)-positive
breast cancer cells (represented by MCF7), and significantly
upregulates miR-29b in ER-negative cells (represented by
MDA-MB-231)”. Was Incorrect, the correct statement is
“In the present study, we show that S100A7 significantly
upregulates the expression of miR-29b in Estrogen Re-
ceptor (ER)-positive breast cancer cells (represented
by MCF7), and significantly downregulates miR-29b in
ER-negative cells (represented by MDA-MB-231)”.
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